{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:19:01Z","timestamp":1787905141737,"version":"build-2784847793"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-026-09197-9","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:47:23Z","timestamp":1787903243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond B cells: T and Innate Immune Mechanisms of Autoimmunity in Common Variable Immunodeficiency"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-1474","authenticated-orcid":false,"given":"Paulina","family":"Kowalczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-555X","authenticated-orcid":false,"given":"Katarzyna","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-5346","authenticated-orcid":false,"given":"Natalia","family":"Sowa-Rogozi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-3988","authenticated-orcid":false,"given":"Monika","family":"Majewska-Szczepanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-4009","authenticated-orcid":false,"given":"Marcin","family":"Zi\u0119tkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"9197_CR1","doi-asserted-by":"publisher","unstructured":"Cunningham-Rundles C (2026) Current concepts: Common variable immunodeficiency. Annals of Allergy, Asthma & Immunology 136:376\u2013386. https:\/\/doi.org\/10.1016\/J.ANAI.2025.11.009","DOI":"10.1016\/J.ANAI.2025.11.009"},{"key":"9197_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2017.01190","volume":"8","author":"JS Selenius","year":"2017","unstructured":"Selenius JS, Martelius T, Pikkarainen S et al (2017) Unexpectedly high prevalence of common variable immunodeficiency in Finland. Front Immunol 8:1190. https:\/\/doi.org\/10.3389\/FIMMU.2017.01190","journal-title":"Front Immunol"},{"key":"9197_CR3","doi-asserted-by":"publisher","unstructured":"Ballow M, S\u00e1nchez-Ram\u00f3n S, Walter JE (2022) Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases. Front Immunol 13:928062. https:\/\/doi.org\/10.3389\/FIMMU.2022.928062","DOI":"10.3389\/FIMMU.2022.928062"},{"key":"9197_CR4","doi-asserted-by":"publisher","unstructured":"Seidel MG, Kindle G, Gathmann B, et al (2019) The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. Journal of Allergy and Clinical Immunology: In Practice 7:1763\u20131770. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.004","DOI":"10.1016\/j.jaip.2019.02.004"},{"key":"9197_CR5","doi-asserted-by":"publisher","unstructured":"Ho HE, Cunningham-Rundles C (2020) Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis. Front Immunol 11:501959. https:\/\/doi.org\/10.3389\/FIMMU.2020.00149\/PDF","DOI":"10.3389\/FIMMU.2020.00149\/PDF"},{"key":"9197_CR6","doi-asserted-by":"publisher","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119:1650\u20131657. https:\/\/doi.org\/10.1182\/BLOOD-2011-09-377945","DOI":"10.1182\/BLOOD-2011-09-377945"},{"key":"9197_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/1744666X.2021.1850272","volume":"16","author":"FS Rizvi","year":"2020","unstructured":"Rizvi FS, Zainaldain H, Rafiemanesh H et al (2020) Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis. Expert Rev Clin Immunol 16:1227\u20131235. https:\/\/doi.org\/10.1080\/1744666X.2021.1850272","journal-title":"Expert Rev Clin Immunol"},{"key":"9197_CR8","doi-asserted-by":"publisher","unstructured":"Bousfiha AA, Jeddane L, Moundir A, et al (2025) The 2024 update of IUIS phenotypic classification of human inborn errors of immunity. Journal of Human Immunity 1:. https:\/\/doi.org\/10.70962\/JHI.20250002\/277374","DOI":"10.70962\/JHI.20250002\/277374"},{"key":"9197_CR9","doi-asserted-by":"publisher","unstructured":"Bousfiha A, Moundir A, Tangye SG, et al (2022) The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. Journal of Clinical Immunology 2022 42:7 42:1508\u20131520. https:\/\/doi.org\/10.1007\/S10875-022-01352-Z","DOI":"10.1007\/S10875-022-01352-Z"},{"key":"9197_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00637","author":"D Paquin-Proulx","year":"2014","unstructured":"Paquin-Proulx D, Sandberg JK (2014) Persistent immune activation in CVID and the role of IVIg in its suppression. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2014.00637","journal-title":"Front Immunol"},{"key":"9197_CR11","doi-asserted-by":"publisher","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, et al (2022) Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 42:1473\u20131507. https:\/\/doi.org\/10.1007\/S10875-022-01289-3","DOI":"10.1007\/S10875-022-01289-3"},{"key":"9197_CR12","doi-asserted-by":"publisher","unstructured":"Poli MC, Aksentijevich I, Bousfiha AA, et al (2025) Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. Journal of Human Immunity 1:e20250003. https:\/\/doi.org\/10.70962\/JHI.20250003","DOI":"10.70962\/JHI.20250003"},{"key":"9197_CR13","doi-asserted-by":"publisher","unstructured":"Bateman EAL, Ayers L, Sadler R, et al (2012) T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 170:202\u2013211. https:\/\/doi.org\/10.1111\/J.1365-2249.2012.04643.X","DOI":"10.1111\/J.1365-2249.2012.04643.X"},{"key":"9197_CR14","doi-asserted-by":"publisher","unstructured":"Sadi Aykan F, \u00c7\u00f6lkesen F, Evcen R, et al (2024) Common variable immunodeficiency and autoimmune diseases: A 10-year single-center experience. Arch Rheumatol 39:588\u2013597. https:\/\/doi.org\/10.46497\/ARCHRHEUMATOL.2024.10729","DOI":"10.46497\/ARCHRHEUMATOL.2024.10729"},{"key":"9197_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.652487","author":"I Mormile","year":"2021","unstructured":"Mormile I, Punziano A, Riolo CA et al (2021) Common variable immunodeficiency and autoimmune diseases: a retrospective study of 95 adult patients in a single tertiary care center. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2021.652487","journal-title":"Front Immunol"},{"key":"9197_CR16","doi-asserted-by":"publisher","unstructured":"Berbers RM, van der Wal MM, van Montfrans JM, et al (2021) Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency. J Clin Immunol 41:1621\u20131632. https:\/\/doi.org\/10.1007\/S10875-021-01084-6","DOI":"10.1007\/S10875-021-01084-6"},{"key":"9197_CR17","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.4049\/JIMMUNOL.178.6.3932","volume":"178","author":"A Giovannetti","year":"2007","unstructured":"Giovannetti A, Pierdominici M, Mazzetta F et al (2007) Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 178:3932\u20133943. https:\/\/doi.org\/10.4049\/JIMMUNOL.178.6.3932","journal-title":"J Immunol"},{"key":"9197_CR18","unstructured":"Oraei M, Aghamohammadi A, Rezaei N, et al (2012) Naive CD4\u2009+\u2009T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol 22:160\u2013167"},{"key":"9197_CR19","doi-asserted-by":"publisher","unstructured":"\u00c1lvarez-\u00c1lvarez JA, V\u00e1squez-Echeverri E, S\u00e1nchez IP, et al (2025) Percentages of Effector Memory T Cells in Peripheral Blood Associated With Non-Infectious Comorbidities in Common Variable Immunodeficiency Disorders. Scand J Immunol 101:. https:\/\/doi.org\/10.1111\/sji.70037","DOI":"10.1111\/sji.70037"},{"key":"9197_CR20","doi-asserted-by":"publisher","unstructured":"Wi\u0119sik-Szewczyk E, Rutkowska E, Kwiecie\u0144 I, et al (2021) Patients with common variable immunodeficiency complicated by autoimmune phenomena have lymphopenia and reduced treg, Th17, and NK cells. J Clin Med 10:. https:\/\/doi.org\/10.3390\/jcm10153356","DOI":"10.3390\/jcm10153356"},{"key":"9197_CR21","doi-asserted-by":"publisher","unstructured":"Hultberg J, Blixt E, G\u00f6ransson R, et al (2023) In-depth immune profiling reveals advanced B- and T-cell differentiation to be associated with Th1-driven immune dysregulation in common variable immunodeficiency. Clinical Immunology 257:. https:\/\/doi.org\/10.1016\/j.clim.2023.109816","DOI":"10.1016\/j.clim.2023.109816"},{"key":"9197_CR22","doi-asserted-by":"publisher","unstructured":"Soltani M, Rezaei M, Fekrvand S, et al (2022) Role of rare immune cells in common variable immunodeficiency. Pediatric Allergy and Immunology 33:. https:\/\/doi.org\/10.1111\/PAI.13725","DOI":"10.1111\/PAI.13725"},{"key":"9197_CR23","doi-asserted-by":"publisher","unstructured":"de Lollo C, Vasconcelos D de M, da Silva Oliveira LM, et al (2016) Impaired CD8\u2009+\u2009T cell responses upon Toll-like receptor activation in common variable immunodeficiency. J Transl Med 14:138. https:\/\/doi.org\/10.1186\/S12967-016-0900-2","DOI":"10.1186\/S12967-016-0900-2"},{"key":"9197_CR24","doi-asserted-by":"publisher","unstructured":"Azizi G, Mirshafiey A, Abolhassani H, et al (2018) Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodeficiency Without Known Monogenic Disease. J Investig Allergol Clin Immunol 28:172\u2013181. https:\/\/doi.org\/10.18176\/JIACI.0231","DOI":"10.18176\/JIACI.0231"},{"key":"9197_CR25","doi-asserted-by":"publisher","unstructured":"Abyazi ML, Bell KA, Gyimesi G, et al (2022) Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications. Journal of Allergy and Clinical Immunology 149:315\u2013326.e9. https:\/\/doi.org\/10.1016\/j.jaci.2021.06.008","DOI":"10.1016\/j.jaci.2021.06.008"},{"key":"9197_CR26","doi-asserted-by":"publisher","unstructured":"Berbers R-M, Drylewicz J, Ellerbroek PM, et al (2021) Targeted Proteomics Reveals Inflammatory Pathways that Classify Immune Dysregulation in Common Variable Immunodeficiency Content courtesy of Springer Nature, terms of use apply. Rights reserved. J Clin Immunol 41:362\u2013373. https:\/\/doi.org\/10.1007\/s10875-020-00908-1\/Published","DOI":"10.1007\/s10875-020-00908-1\/Published"},{"key":"9197_CR27","doi-asserted-by":"publisher","unstructured":"Barbosa RR, Silva SP, Silva SL, et al (2011) Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation. PLoS One 6:. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0022848","DOI":"10.1371\/JOURNAL.PONE.0022848"},{"key":"9197_CR28","doi-asserted-by":"publisher","unstructured":"Oliveira AKB De, Neves MAA, Salmazi KC, et al (2015) Evaluation of TH17 profile in common variable immunodeficiency patients with or without autoimmunity. World Allergy Organ J 8:A236. https:\/\/doi.org\/10.1186\/1939-4551-8-S1-A236","DOI":"10.1186\/1939-4551-8-S1-A236"},{"key":"9197_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2010.10.002","volume":"36","author":"J Boileau","year":"2011","unstructured":"Boileau J, Mouillot G, G\u00e9rard L et al (2011) Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun 36:25\u201332. https:\/\/doi.org\/10.1016\/j.jaut.2010.10.002","journal-title":"J Autoimmun"},{"key":"9197_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/J.1365-2249.2000.01239.X","volume":"120","author":"M Di Renzo","year":"2001","unstructured":"Di Renzo M, Zhou Z, George I et al (2001) Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation. Clin Exp Immunol 120:503\u2013511. https:\/\/doi.org\/10.1046\/J.1365-2249.2000.01239.X","journal-title":"Clin Exp Immunol"},{"key":"9197_CR31","doi-asserted-by":"publisher","unstructured":"Wong GK, Millar D, Penny S, et al (2016) Accelerated Loss of TCR Repertoire Diversity in Common Variable Immunodeficiency. The Journal of Immunology 197:1642\u20131649. https:\/\/doi.org\/10.4049\/JIMMUNOL.1600526","DOI":"10.4049\/JIMMUNOL.1600526"},{"key":"9197_CR32","doi-asserted-by":"publisher","unstructured":"Unger S, Seidl M, van Schouwenburg P, et al (2018) The TH1 phenotype of follicular helper T cells indicates an IFN-\u03b3\u2013associated immune dysregulation in patients with CD21low common variable immunodeficiency. Journal of Allergy and Clinical Immunology 141:730\u2013740. https:\/\/doi.org\/10.1016\/j.jaci.2017.04.041","DOI":"10.1016\/j.jaci.2017.04.041"},{"key":"9197_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jaci.2020.01.046","volume":"146","author":"J Hultberg","year":"2020","unstructured":"Hultberg J, Ernerudh J, Larsson M et al (2020) Plasma protein profiling reflects TH1-driven immune dysregulation in common variable immunodeficiency. J Allergy Clin Immunol 146:417\u2013428. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.046","journal-title":"J Allergy Clin Immunol"},{"key":"9197_CR34","doi-asserted-by":"publisher","unstructured":"Azizi G, Bagheri Y, Yazdani R, et al (2019) The profile of IL-4, IL-5, IL-10 and GATA3 in patients with LRBA deficiency and CVID with no known monogenic disease: Association with disease severity. Allergol Immunopathol (Madr) 47:172\u2013178. https:\/\/doi.org\/10.1016\/J.ALLER.2018.06.003","DOI":"10.1016\/J.ALLER.2018.06.003"},{"key":"9197_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.18176\/JIACI.0302","volume":"28","author":"G Azizi","year":"2018","unstructured":"Azizi G, Jamee M, Yazdani R et al (2018) CTLA-4 expression in CD4+ T cells from patients with LRBA deficiency and common variable immunodeficiency with no known monogenic disease. J Investig Allergol Clin Immunol 28:422\u2013424. https:\/\/doi.org\/10.18176\/JIACI.0302","journal-title":"J Investig Allergol Clin Immunol"},{"key":"9197_CR36","doi-asserted-by":"publisher","unstructured":"Taraldsrud E, Fevang B, J\u00f8rgensen SF, et al (2017) Defective IL-4 signaling in T cells defines severe common variable immunodeficiency. J Autoimmun 81:110\u2013119. https:\/\/doi.org\/10.1016\/J.JAUT.2017.04.004","DOI":"10.1016\/J.JAUT.2017.04.004"},{"key":"9197_CR37","doi-asserted-by":"publisher","unstructured":"Malphettes M, G\u00e9rard L, Carmagnat M, et al (2009) Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 49:1329\u20131338. https:\/\/doi.org\/10.1086\/606059","DOI":"10.1086\/606059"},{"key":"9197_CR38","doi-asserted-by":"publisher","unstructured":"von Spee-Mayer C, Echternach C, Agarwal P, et al (2021) Abatacept Use Is Associated with Steroid Dose Reduction and Improvement in Fatigue and CD4-Dysregulation in CVID Patients with Interstitial Lung Disease. J Allergy Clin Immunol Pract 9:760\u2013770.e10. https:\/\/doi.org\/10.1016\/J.JAIP.2020.10.028","DOI":"10.1016\/J.JAIP.2020.10.028"},{"key":"9197_CR39","doi-asserted-by":"publisher","unstructured":"Arumugakani G, Wood PMD, Carter CRD (2009) Frequency of Treg Cells Is Reduced in CVID Patients with Autoimmunity and Splenomegaly and Is Associated with Expanded CD21lo B Lymphocytes. Journal of Clinical Immunology 2009 30:2 30:292\u2013300. https:\/\/doi.org\/10.1007\/S10875-009-9351-3","DOI":"10.1007\/S10875-009-9351-3"},{"key":"9197_CR40","doi-asserted-by":"publisher","unstructured":"Melo KM, Carvalho KI, Bruno FR, et al (2009) A Decreased Frequency of Regulatory T Cells in Patients with Common Variable Immunodeficiency. PLoS One 4:e6269. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0006269","DOI":"10.1371\/JOURNAL.PONE.0006269"},{"key":"9197_CR41","doi-asserted-by":"publisher","unstructured":"Horn J, Manguiat A, Berglund LJ, et al (2009) Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 156:446\u2013454. https:\/\/doi.org\/10.1111\/J.1365-2249.2009.03913.X","DOI":"10.1111\/J.1365-2249.2009.03913.X"},{"key":"9197_CR42","doi-asserted-by":"publisher","unstructured":"Azizi G, Rezaei N, Kiaee F, et al (2016) T-Cell Abnormalities in Common Variable Immunodeficiency. J Investig Allergol Clin Immunol 26:233\u2013243. https:\/\/doi.org\/10.18176\/JIACI.0069","DOI":"10.18176\/JIACI.0069"},{"key":"9197_CR43","doi-asserted-by":"publisher","unstructured":"Carter CRD, Aravind G, Smalle NL, et al (2013) CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells. J Clin Pathol 66:146\u2013150. https:\/\/doi.org\/10.1136\/JCLINPATH-2012-201046","DOI":"10.1136\/JCLINPATH-2012-201046"},{"key":"9197_CR44","doi-asserted-by":"publisher","unstructured":"Nowak E, Sulicka-Grodzicka J, Strach M, et al (2020) Decreased number of regulatory T lymphocytes is related to inflammation and number of CD8\u2009+\u2009T cells expressing programmed cell death protein-1 in common variable immunodeficiency. Folia Med Cracov 60:5\u201316. https:\/\/doi.org\/10.24425\/FMC.2020.135791","DOI":"10.24425\/FMC.2020.135791"},{"key":"9197_CR45","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Herrera G, Segura-M\u00e9ndez NH, O\u2019Farril-Romanillos P, et al (2019) Low percentages of regulatory T cells in common variable immunodeficiency (CVID) patients with autoimmune diseases and its association with increased numbers of CD4\u2009+\u2009CD45RO\u2009+\u2009T and CD21low B cells. Allergol Immunopathol (Madr) 47:457\u2013466. https:\/\/doi.org\/10.1016\/J.ALLER.2019.01.003","DOI":"10.1016\/J.ALLER.2019.01.003"},{"key":"9197_CR46","doi-asserted-by":"publisher","unstructured":"Lishchuk-Yakymovych K, Pukaliak R, Synenkyi O, et al (2025) T-REGULATORY LYMPHOCYTES IN PATIENTS WITH ANTIBODY DEFICIENCY AND MANIFESTATIONS OF SECONDARY SYSTEMIC VASCULITIS. Proceeding of the Shevchenko Scientific Society Medical Sciences 77:1\u20139. https:\/\/doi.org\/10.25040\/NTSH2025.01.19","DOI":"10.25040\/NTSH2025.01.19"},{"key":"9197_CR47","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/JCLINPATH-2015-203351","volume":"69","author":"GK Wong","year":"2016","unstructured":"Wong GK, Huissoon AP (2016) T-cell abnormalities in common variable immunodeficiency: the hidden defect. J Clin Pathol 69:672\u2013676. https:\/\/doi.org\/10.1136\/JCLINPATH-2015-203351","journal-title":"J Clin Pathol"},{"key":"9197_CR48","doi-asserted-by":"publisher","unstructured":"Yu GP, Chiang D, Song SJ, et al (2009) Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clinical Immunology 131:240\u2013253. https:\/\/doi.org\/10.1016\/j.clim.2008.12.006","DOI":"10.1016\/j.clim.2008.12.006"},{"key":"9197_CR49","doi-asserted-by":"publisher","unstructured":"Arandi N, Mirshafiey A, Jeddi-Tehrani M, et al (2013) Evaluation of CD4\u2009+\u2009CD25+FOXP3\u2009+\u2009regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol 281:129\u2013133. https:\/\/doi.org\/10.1016\/J.CELLIMM.2013.03.003","DOI":"10.1016\/J.CELLIMM.2013.03.003"},{"key":"9197_CR50","doi-asserted-by":"publisher","unstructured":"Arandi N, Mirshafiey A, Abolhassani H, et al (2013) Frequency and Expression of Inhibitory Markers of CD4\u2009+\u2009CD25+FOXP3\u2009+\u2009Regulatory T Cells in Patients with Common Variable Immunodeficiency. Scand J Immunol 77:405\u2013412. https:\/\/doi.org\/10.1111\/SJI.12040;REQUESTEDJOURNAL:JOURNAL:13653083","DOI":"10.1111\/SJI.12040;REQUESTEDJOURNAL:JOURNAL:13653083"},{"key":"9197_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/J.CLIM.2009.03.519","volume":"132","author":"J Genre","year":"2009","unstructured":"Genre J, Errante PR, Kokron CM et al (2009) Reduced frequency of CD4\u2009+\u2009CD25HIGHFOXP3+ cells and diminished FOXP3 expression in patients with common variable immunodeficiency: a link to autoimmunity? Clin Immunol 132:215\u2013221. https:\/\/doi.org\/10.1016\/J.CLIM.2009.03.519","journal-title":"Clin Immunol"},{"key":"9197_CR52","doi-asserted-by":"publisher","unstructured":"Kofod-Olsen E, J\u00f8rgensen SE, Nissen SK, et al (2016) Altered fraction of regulatory B and T cells is correlated with autoimmune phenomena and splenomegaly in patients with CVID. https:\/\/doi.org\/10.1016\/j.clim.2015.11.003","DOI":"10.1016\/j.clim.2015.11.003"},{"key":"9197_CR53","doi-asserted-by":"publisher","unstructured":"Edwards ESJ, Bosco JJ, Aui PM, et al (2019) Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells. Front Immunol 10:490169. https:\/\/doi.org\/10.3389\/FIMMU.2019.02593\/FULL","DOI":"10.3389\/FIMMU.2019.02593\/FULL"},{"key":"9197_CR54","doi-asserted-by":"publisher","unstructured":"Gereige JD, Maglione PJ (2019) Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity. Front Immunol 10:2753. https:\/\/doi.org\/10.3389\/FIMMU.2019.02753","DOI":"10.3389\/FIMMU.2019.02753"},{"key":"9197_CR55","doi-asserted-by":"publisher","unstructured":"Romberg N, Le Coz C, Glauzy S, et al (2019) Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses. Journal of Allergy and Clinical Immunology 143:258\u2013265. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.012","DOI":"10.1016\/j.jaci.2018.06.012"},{"key":"9197_CR56","doi-asserted-by":"publisher","unstructured":"Shouse AN, LaPorte KM, Malek TR (2024) Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer. Immunity 57:414\u2013428. https:\/\/doi.org\/10.1016\/j.immuni.2024.02.001","DOI":"10.1016\/j.immuni.2024.02.001"},{"key":"9197_CR57","doi-asserted-by":"publisher","unstructured":"Babaha F, Yazdani R, Shahkarami S, et al (2021) Evaluation of miR-210 expression in common variable immunodeficiency: patients with unsolved genetic defect. Allergol Immunopathol (Madr) 49:84\u201393. https:\/\/doi.org\/10.15586\/AEI.V49I2.39","DOI":"10.15586\/AEI.V49I2.39"},{"key":"9197_CR58","doi-asserted-by":"publisher","unstructured":"Rutkowska-Zapa\u0142a M, Grabowska-Gurgul A, Lenart M, et al (2024) Gene Signature of Regulatory T Cells Isolated from Children with Selective IgA Deficiency and Common Variable Immunodeficiency. Cells 13:417. https:\/\/doi.org\/10.3390\/CELLS13050417\/S1","DOI":"10.3390\/CELLS13050417\/S1"},{"key":"9197_CR59","doi-asserted-by":"publisher","unstructured":"Yu WQ, Ji NF, Gu CJ, et al (2021) Coexpression of Helios in Foxp3\u2009+\u2009Regulatory T Cells and Its Role in Human Disease. Dis Markers 2021:5574472. https:\/\/doi.org\/10.1155\/2021\/5574472","DOI":"10.1155\/2021\/5574472"},{"key":"9197_CR60","doi-asserted-by":"publisher","unstructured":"Polak K, Marchal P, Taroni C, et al (2023) CD4\u2009+\u2009regulatory T cells lacking Helios and Eos. Biochem Biophys Res Commun 674:83\u201389. https:\/\/doi.org\/10.1016\/J.BBRC.2023.06.087","DOI":"10.1016\/J.BBRC.2023.06.087"},{"key":"9197_CR61","doi-asserted-by":"publisher","unstructured":"Kennedy-Batalla R, Acevedo D, Luo Y, et al (2024) Treg in inborn errors of immunity: gaps, knowns and future perspectives. Front Immunol 14:. https:\/\/doi.org\/10.3389\/FIMMU.2023.1278759","DOI":"10.3389\/FIMMU.2023.1278759"},{"key":"9197_CR62","doi-asserted-by":"publisher","unstructured":"Donhauser S, Salzmann-Manrique E, Lueck LM, et al (2026) Abatacept treatment shows a modulating effect on Treg subsets in LRBA-deficient patients. Front Immunol 17:1697915. https:\/\/doi.org\/10.3389\/FIMMU.2026.1697915\/TEXT","DOI":"10.3389\/FIMMU.2026.1697915\/TEXT"},{"key":"9197_CR63","doi-asserted-by":"publisher","unstructured":"Boutboul D, Kuehn HS, Van De Wyngaert Z, et al (2018) Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest 128:3071\u20133087. https:\/\/doi.org\/10.1172\/JCI98164","DOI":"10.1172\/JCI98164"},{"key":"9197_CR64","doi-asserted-by":"publisher","unstructured":"Thomas RM, Pahl MC, Wang L, et al (2024) Foxp3 depends on Ikaros for control of regulatory T cell gene expression and function. Elife 12:. https:\/\/doi.org\/10.7554\/ELIFE.91392","DOI":"10.7554\/ELIFE.91392"},{"key":"9197_CR65","doi-asserted-by":"publisher","unstructured":"Coraglia A, Galassi N, Fern\u00e1ndez Romero DS, et al (2016) Common Variable Immunodeficiency and Circulating TFH. J Immunol Res 2016:. https:\/\/doi.org\/10.1155\/2016\/4951587","DOI":"10.1155\/2016\/4951587"},{"key":"9197_CR66","doi-asserted-by":"publisher","unstructured":"Cunill V, Clemente A, Lanio N, et al (2017) Follicular T cells from smB- common variable immunodeficiency patients are skewed toward a Th1 phenotype. Front Immunol 8:. https:\/\/doi.org\/10.3389\/fimmu.2017.00174","DOI":"10.3389\/fimmu.2017.00174"},{"key":"9197_CR67","doi-asserted-by":"publisher","unstructured":"Yesillik S, Gupta S (2020) Phenotypically defined subpopulations of circulating follicular helper T cells in common variable immunodeficiency. Immun Inflamm Dis 8:441\u2013446. https:\/\/doi.org\/10.1002\/iid3.326","DOI":"10.1002\/iid3.326"},{"key":"9197_CR68","doi-asserted-by":"publisher","unstructured":"Le Saos-Patrinos C, Loizon S, Blanco P et al (2020) Functions of Tfh cells in common variable immunodeficiency. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00006","DOI":"10.3389\/fimmu.2020.00006"},{"key":"9197_CR69","doi-asserted-by":"publisher","unstructured":"Kasahara TDM, Bento CADM, Gupta S (2020) Phenotypic and Functional Analysis of T Follicular Cells in Common Variable Immunodeficiency. Int Arch Allergy Immunol 181:635\u2013647. https:\/\/doi.org\/10.1159\/000507995","DOI":"10.1159\/000507995"},{"key":"9197_CR70","doi-asserted-by":"publisher","unstructured":"Klocperk A, Unger S, Friedmann D, et al (2020) Exhausted phenotype of follicular CD8 T cells in CVID. Journal of Allergy and Clinical Immunology 146:912\u2013915.e13. https:\/\/doi.org\/10.1016\/j.jaci.2020.02.025","DOI":"10.1016\/j.jaci.2020.02.025"},{"key":"9197_CR71","doi-asserted-by":"publisher","unstructured":"Caldirola MS, Mart\u00ednez MP, Bezrodnik L, et al (2020) Immune Monitoring of Patients With Primary Immune Regulation Disorders Unravels Higher Frequencies of Follicular T Cells With Different Profiles That Associate With Alterations in B Cell Subsets. Front Immunol 11:. https:\/\/doi.org\/10.3389\/fimmu.2020.576724","DOI":"10.3389\/fimmu.2020.576724"},{"key":"9197_CR72","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/eji.202149480","volume":"52","author":"G Milardi","year":"2022","unstructured":"Milardi G, Di Lorenzo B, Gerosa J et al (2022) Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency. Eur J Immunol 52:1171\u20131189. https:\/\/doi.org\/10.1002\/eji.202149480","journal-title":"Eur J Immunol"},{"key":"9197_CR73","doi-asserted-by":"publisher","unstructured":"Le Coz C, Bengsch B, Khanna C, et al (2019) Common variable immunodeficiency\u2013associated endotoxemia promotes early commitment to the T follicular lineage. Journal of Allergy and Clinical Immunology 144:1660\u20131673. https:\/\/doi.org\/10.1016\/j.jaci.2019.08.007","DOI":"10.1016\/j.jaci.2019.08.007"},{"key":"9197_CR74","doi-asserted-by":"publisher","unstructured":"Sepahi A, Ho H en, Vyas P, et al (2024) ICOS agonist vopratelimab modulates follicular helper T cells and improves B cell function in common variable immunodeficiency. Clinical Immunology 264:. https:\/\/doi.org\/10.1016\/j.clim.2024.110217","DOI":"10.1016\/j.clim.2024.110217"},{"key":"9197_CR75","doi-asserted-by":"publisher","unstructured":"Friedmann D, Payne KJ, Cousin V, et al (2025) Expansion of a distinct cytotoxic CD4 TFH-cell cluster in lymph nodes of patients with complicated common variable immunodeficiency. Journal of Allergy and Clinical Immunology. https:\/\/doi.org\/10.1016\/j.jaci.2025.09.032","DOI":"10.1016\/j.jaci.2025.09.032"},{"key":"9197_CR76","doi-asserted-by":"publisher","unstructured":"Azizi G, Abolhassani H, Kiaee F, et al (2018) Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency. Allergol Immunopathol (Madr) 46:127\u2013135. https:\/\/doi.org\/10.1016\/j.aller.2017.04.004","DOI":"10.1016\/j.aller.2017.04.004"},{"key":"9197_CR77","doi-asserted-by":"publisher","unstructured":"Rakhmanov M, Keller B, Gutenberger S, et al (2009) Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A 106:13451\u201313456. https:\/\/doi.org\/10.1073\/PNAS.0901984106","DOI":"10.1073\/PNAS.0901984106"},{"key":"9197_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.535784","author":"ME Reincke","year":"2020","unstructured":"Reincke ME, Payne KJ, Harder I et al (2020) The antigen presenting potential of CD21low B cells. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2020.535784","journal-title":"Front Immunol"},{"key":"9197_CR79","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/CEI\/UXAC103","volume":"210","author":"I Gjertsson","year":"2022","unstructured":"Gjertsson I, Mcgrath S, Grimstad K et al (2022) A close-up on the expanding landscape of CD21\u2013\/low B cells in humans. Clin Exp Immunol 210:217. https:\/\/doi.org\/10.1093\/CEI\/UXAC103","journal-title":"Clin Exp Immunol"},{"key":"9197_CR80","doi-asserted-by":"publisher","unstructured":"Warnatz K, Voll RE (2012) Pathogenesis of autoimmunity in common variable immunodeficiency. Front Immunol 3:210. https:\/\/doi.org\/10.3389\/FIMMU.2012.00210","DOI":"10.3389\/FIMMU.2012.00210"},{"key":"9197_CR81","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jaci.2017.05.022","volume":"141","author":"FJ Alroqi","year":"2018","unstructured":"Alroqi FJ, Charbonnier LM, Baris S et al (2018) Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation. J Allergy Clin Immunol 141:1050-1059.e10. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.022","journal-title":"J Allergy Clin Immunol"},{"key":"9197_CR82","doi-asserted-by":"publisher","unstructured":"JS J, E E, MC S, W S (1993) T-cell abnormalities in common variable immunodeficiency. Pediatr Res 33:S24\u2013S24. https:\/\/doi.org\/10.1203\/00006450-199305001-00128","DOI":"10.1203\/00006450-199305001-00128"},{"key":"9197_CR83","doi-asserted-by":"crossref","unstructured":"Jaffe J, Strober W, Sneller M (1993) Functional abnormalities of CD8\u2009+\u2009T cells define a unique subset of patients with common variable immunodeficiency - PubMed. Blood 82:192\u2013201","DOI":"10.1182\/blood.V82.1.192.bloodjournal821192"},{"key":"9197_CR84","doi-asserted-by":"publisher","unstructured":"Kuntz M, Goldacker S, Blum HE, et al (2011) Analysis of bulk and virus-specific CD8\u2009+\u2009T cells reveals advanced differentiation of CD8\u2009+\u2009T cells in patients with common variable immunodeficiency. Clin Immunol 141:177\u2013186. https:\/\/doi.org\/10.1016\/J.CLIM.2011.07.006","DOI":"10.1016\/J.CLIM.2011.07.006"},{"key":"9197_CR85","doi-asserted-by":"publisher","unstructured":"Klocperk A, Friedmann D, Schlaak AE, et al (2022) Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency. J Clin Immunol 42:1254\u20131269. https:\/\/doi.org\/10.1007\/S10875-022-01291-9","DOI":"10.1007\/S10875-022-01291-9"},{"key":"9197_CR86","doi-asserted-by":"publisher","unstructured":"Bez P, Santangeli E, Goldacker S, et al (2025) Expansion of CD57\u2009+\u2009CD8 T cells in common variable immunodeficiency with hepatopathy and CMV infection. Front Immunol 16:. https:\/\/doi.org\/10.3389\/FIMMU.2025.1577934","DOI":"10.3389\/FIMMU.2025.1577934"},{"key":"9197_CR87","doi-asserted-by":"publisher","unstructured":"Viallard JF, Blanco P, Andr\u00e9 M, et al (2006) CD8\u2009+\u2009HLA-DR\u2009+\u2009T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clinical Immunology 119:51\u201358. https:\/\/doi.org\/10.1016\/j.clim.2005.11.011","DOI":"10.1016\/j.clim.2005.11.011"},{"key":"9197_CR88","doi-asserted-by":"publisher","unstructured":"North ME, Webster ADB, Farrant J (1998) Primary defect in CD8\u2009+\u2009lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ (\u2018cytotoxic\u2019) and CD28- (\u2018suppressor\u2019) CD8\u2009+\u2009subsets. Clin Exp Immunol 111:70\u201375. https:\/\/doi.org\/10.1046\/J.1365-2249.1998.00479.X","DOI":"10.1046\/J.1365-2249.1998.00479.X"},{"key":"9197_CR89","doi-asserted-by":"publisher","unstructured":"Viallard JF, Parrens M, Blanco P, et al (2024) Influence of Splenomegaly and Splenectomy on the Immune Cell Profile of Patients with Common Variable Immunodeficiency Disease. Journal of Clinical Immunology 2024 44:2 44:46-. https:\/\/doi.org\/10.1007\/S10875-023-01648-8","DOI":"10.1007\/S10875-023-01648-8"},{"key":"9197_CR90","doi-asserted-by":"publisher","unstructured":"Wong GK, Goldacker S, Winterhalter C, et al (2013) Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients. Clin Exp Immunol 172:63\u201372. https:\/\/doi.org\/10.1111\/CEI.12039","DOI":"10.1111\/CEI.12039"},{"key":"9197_CR91","doi-asserted-by":"publisher","unstructured":"Marashi SM, Raeiszadeh M, Workman S, et al (2011) Inflammation in common variable immunodeficiency is associated with a distinct CD8\u2009+\u2009response to cytomegalovirus. Journal of Allergy and Clinical Immunology 127:1385\u20131393.e4. https:\/\/doi.org\/10.1016\/J.JACI.2011.04.001","DOI":"10.1016\/J.JACI.2011.04.001"},{"key":"9197_CR92","doi-asserted-by":"publisher","unstructured":"Marashi SM, Raeiszadeh M, Enright V, et al (2012) Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency. Journal of Allergy and Clinical Immunology 129:. https:\/\/doi.org\/10.1016\/j.jaci.2012.02.011","DOI":"10.1016\/j.jaci.2012.02.011"},{"key":"9197_CR93","doi-asserted-by":"publisher","unstructured":"Raeiszadeh M, Kopycinski J, Paston SJ, et al (2006) The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin Exp Immunol 146:234\u2013242. https:\/\/doi.org\/10.1111\/J.1365-2249.2006.03209.X","DOI":"10.1111\/J.1365-2249.2006.03209.X"},{"key":"9197_CR94","doi-asserted-by":"publisher","unstructured":"Kahn A, Luque G, Cuestas E, et al (2024) Immunological biomarkers associated with survival in a cohort of Argentinian patients with common variable immunodeficiency. The journal of allergy and clinical immunology Global 3:. https:\/\/doi.org\/10.1016\/J.JACIG.2024.100311","DOI":"10.1016\/J.JACIG.2024.100311"},{"key":"9197_CR95","doi-asserted-by":"publisher","unstructured":"Shin JJ, Liauw D, Siddiqui S, et al (2020) Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum. J Clin Immunol 40:592\u2013601. https:\/\/doi.org\/10.1007\/S10875-020-00773-Y","DOI":"10.1007\/S10875-020-00773-Y"},{"key":"9197_CR96","doi-asserted-by":"publisher","unstructured":"Yildiz E, Colkesen F, Evcen R, et al (2024) The clinical and immunological characteristics of common variable immunodeficiency in adults and older adults. North Clin Istanb 11:201. https:\/\/doi.org\/10.14744\/NCI.2023.49699","DOI":"10.14744\/NCI.2023.49699"},{"key":"9197_CR97","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2249.2000.01317.x","volume":"121","author":"RM Aspalter","year":"2000","unstructured":"Aspalter RM, Sewell WAC, Dolman K et al (2000) Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol 121:506\u2013514","journal-title":"Clin Exp Immunol"},{"key":"9197_CR98","doi-asserted-by":"publisher","unstructured":"Srour EF, Leemhuis T, Jenski L, et al (1990) Cytolytic activity of human natural killer cell subpopulations isolated by four-color immunofluorescence flow cytometric cell sorting. Cytometry 11:442\u2013446. https:\/\/doi.org\/10.1002\/CYTO.990110316","DOI":"10.1002\/CYTO.990110316"},{"key":"9197_CR99","unstructured":"Fuchshuber P R, Lotzov\u00e1 E (1992) Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures - PubMed. Lymphokine Cytokine Res"},{"key":"9197_CR100","doi-asserted-by":"publisher","unstructured":"Addison EG, North J, Bakhsh I, et al (2005) Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology 116:354\u2013361. https:\/\/doi.org\/10.1111\/J.1365-2567.2005.02235.X","DOI":"10.1111\/J.1365-2567.2005.02235.X"},{"key":"9197_CR101","unstructured":"Trujillo CM, Muskus C, Arango J, et al (2011) Quantitative and Functional Evaluation of Innate Immune Responses in Patients With Common Variable Immunodefi ciency. Innate Immunity in CVID J Investig Allergol Clin Immunol 21:207\u2013215"},{"key":"9197_CR102","doi-asserted-by":"publisher","unstructured":"Prokopovich SS, \u0421\u0435\u0440\u0433\u0435\u0435\u0432\u043d\u0430 \u041f\u0421, Novikova IA, \u0410\u043b\u0435\u043a\u0441\u0430\u043d\u0434\u0440\u043e\u0432\u043d\u0430 \u041d\u0418 (2022) Killer cell cluster immunity state in adult patients with common variable immunodeficiency. Russian Journal of Immunology 25:93\u201398. https:\/\/doi.org\/10.46235\/1028-7221-1097-KCC","DOI":"10.46235\/1028-7221-1097-KCC"},{"key":"9197_CR103","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ebiom.2016.02.025","volume":"6","author":"M Ebbo","year":"2016","unstructured":"Ebbo M, G\u00e9rard L, Carpentier S et al (2016) Low circulating natural killer cell counts are associated with severe disease in patients with common variable immunodeficiency. EBioMedicine 6:222\u2013230. https:\/\/doi.org\/10.1016\/j.ebiom.2016.02.025","journal-title":"EBioMedicine"},{"key":"9197_CR104","doi-asserted-by":"publisher","unstructured":"Kutukculer N, Azarsiz E, Karaca NE, et al (2015) A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients. Front Immunol 6:. https:\/\/doi.org\/10.3389\/FIMMU.2015.00145","DOI":"10.3389\/FIMMU.2015.00145"},{"key":"9197_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2017.00699","author":"M Amand","year":"2017","unstructured":"Amand M, Iserentant G, Poli A et al (2017) Human CD56dimCD16dim cells as an individualized natural killer cell subset. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2017.00699","journal-title":"Front Immunol"},{"key":"9197_CR106","doi-asserted-by":"publisher","unstructured":"Adin-Cinar S, Gelmez MY, Akdeniz N, et al (2021) Functions of NK and iNKT cells in pediatric and adult CVID, ataxia telangiectasia and agammaglobulinemia patients. Immunol Lett 240:46\u201355. https:\/\/doi.org\/10.1016\/j.imlet.2021.09.008","DOI":"10.1016\/j.imlet.2021.09.008"},{"key":"9197_CR107","doi-asserted-by":"publisher","unstructured":"Carvalho KI, Melo KM, Bruno FR, et al (2010) Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID). PLoS One 5:1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0012652","DOI":"10.1371\/journal.pone.0012652"},{"key":"9197_CR108","doi-asserted-by":"publisher","unstructured":"Erazo-Borr\u00e1s L V., \u00c1lvarez-\u00c1lvarez JA, Perez-Romero CA, et al (2017) Skewed Invariant Natural Killer T (iNKT) Cells, Impaired iNKT:B Cell Help and Decreased SAP Expression in Blood Lymphocytes from Patients with Common Variable Immunodeficiency. Scand J Immunol 86:171\u2013178. https:\/\/doi.org\/10.1111\/sji.12576","DOI":"10.1111\/sji.12576"},{"key":"9197_CR109","doi-asserted-by":"publisher","unstructured":"Arduini S, Dunne J, Conlon N, et al (2017) Mucosal-associated invariant T cells are depleted and functionally altered in patients with common variable immunodeficiency. Clinical Immunology 176:23\u201330. https:\/\/doi.org\/10.1016\/J.CLIM.2016.12.002","DOI":"10.1016\/J.CLIM.2016.12.002"},{"key":"9197_CR110","doi-asserted-by":"publisher","unstructured":"Aukrust P, Froland SS, Muller F (1992) Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features. Clin Exp Immunol 89:211\u2013216. https:\/\/doi.org\/10.1111\/J.1365-2249.1992.TB06934.X","DOI":"10.1111\/J.1365-2249.1992.TB06934.X"},{"key":"9197_CR111","doi-asserted-by":"publisher","unstructured":"Fevang B, Yndestad A, Sandberg WJ, et al (2007) Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo. Clin Exp Immunol 147:521\u2013525. https:\/\/doi.org\/10.1111\/J.1365-2249.2006.03314.X","DOI":"10.1111\/J.1365-2249.2006.03314.X"},{"key":"9197_CR112","doi-asserted-by":"publisher","unstructured":"Aukrust P, Muller F, Froland SS (1994) Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin Exp Immunol 97:232\u2013238. https:\/\/doi.org\/10.1111\/J.1365-2249.1994.TB06073.X","DOI":"10.1111\/J.1365-2249.1994.TB06073.X"},{"key":"9197_CR113","doi-asserted-by":"publisher","unstructured":"Aukrust P, Svardal AM, M\u00fcller F, et al (1995) Decreased Levels of Total and Reduced Glutathione in CD4\u2009+\u2009Lymphocytes in Common Variable Immunodeficiency Are Associated With Activation of the Tumor Necrosis Factor System: Possible Immunopathogenic Role of Oxidative Stress. Blood 86:1383\u20131391. https:\/\/doi.org\/10.1182\/BLOOD.V86.4.1383.BLOODJOURNAL8641383","DOI":"10.1182\/BLOOD.V86.4.1383.BLOODJOURNAL8641383"},{"key":"9197_CR114","doi-asserted-by":"publisher","unstructured":"Perreau M, Vigano S, Bellanger F, et al (2014) Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med 211:2033. https:\/\/doi.org\/10.1084\/JEM.20140039","DOI":"10.1084\/JEM.20140039"},{"key":"9197_CR115","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/mi.2016.18","volume":"9","author":"SF J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen SF, Tr\u00f8seid M, Kummen M et al (2016) Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation. Mucosal Immunol 9:1455\u20131465. https:\/\/doi.org\/10.1038\/mi.2016.18","journal-title":"Mucosal Immunol"},{"key":"9197_CR116","doi-asserted-by":"publisher","unstructured":"Barbosa RR, Silva SP, Silva SL, et al (2012) Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels. Clin Exp Immunol 169:263\u2013272. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04620.x","DOI":"10.1111\/j.1365-2249.2012.04620.x"},{"key":"9197_CR117","doi-asserted-by":"crossref","unstructured":"Cambronero R, Sewell WAC, North ME, et al (2000) Up-Regulation of IL-12 in Monocytes: A Fundamental Defect in Common Variable Immunodeficiency1","DOI":"10.4049\/jimmunol.164.1.488"},{"key":"9197_CR118","doi-asserted-by":"publisher","unstructured":"Cavaliere FM, Prezzo A, Conti V, et al (2015) Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies. Int Immunopharmacol 28:596\u2013603. https:\/\/doi.org\/10.1016\/j.intimp.2015.07.017","DOI":"10.1016\/j.intimp.2015.07.017"},{"key":"9197_CR119","doi-asserted-by":"publisher","unstructured":"Tsinti G, Makris D, Germenis AE, Speletas M (2020) Persistent Activation of Innate Immunity in Patients with Primary Antibody Deficiencies. J Immunol Res 2020:. https:\/\/doi.org\/10.1155\/2020\/8317671","DOI":"10.1155\/2020\/8317671"},{"key":"9197_CR120","doi-asserted-by":"publisher","unstructured":"Litzman J, Nechvatalova J, Xu J, et al (2012) Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia. Clin Exp Immunol 170:321\u2013332. https:\/\/doi.org\/10.1111\/J.1365-2249.2012.04655.X","DOI":"10.1111\/J.1365-2249.2012.04655.X"},{"key":"9197_CR121","doi-asserted-by":"publisher","unstructured":"J\u00f8rgensen SF, Braadland PR, Ueland T, et al (2025) Tryptophan\u2013kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency. Journal of Allergy and Clinical Immunology 156:814\u2013824.e11. https:\/\/doi.org\/10.1016\/j.jaci.2025.04.031","DOI":"10.1016\/j.jaci.2025.04.031"},{"key":"9197_CR122","doi-asserted-by":"publisher","unstructured":"Viallard JF, Camou F, Andr\u00e9 M, et al (2005) Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Ther 7:. https:\/\/doi.org\/10.1186\/ar1774","DOI":"10.1186\/ar1774"},{"key":"9197_CR123","doi-asserted-by":"publisher","unstructured":"Yong PFK, Workman S, Wahid F, et al (2008) Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clinical Immunology 127:34\u201342. https:\/\/doi.org\/10.1016\/j.clim.2007.12.007","DOI":"10.1016\/j.clim.2007.12.007"},{"key":"9197_CR124","doi-asserted-by":"publisher","unstructured":"Taraldsrud E, Fevang B, Aukrust P, et al (2014) Common variable immunodeficiency revisited: Normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. Clin Exp Immunol 175:439\u2013448. https:\/\/doi.org\/10.1111\/cei.12239","DOI":"10.1111\/cei.12239"},{"key":"9197_CR125","doi-asserted-by":"publisher","unstructured":"Martinez-Pomar N, Raga S, Ferrer J, et al (2006) Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: Analysis of IL-12p40 and interferon-\u03b3 gene. Clin Exp Immunol 144:233\u2013238. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03063.x","DOI":"10.1111\/j.1365-2249.2006.03063.x"},{"key":"9197_CR126","doi-asserted-by":"publisher","unstructured":"Bayry J, Lacroix-Desmazes S, Kazatchkine MD, et al (2004) Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104:2441\u20132443. https:\/\/doi.org\/10.1182\/BLOOD-2004-04-1325","DOI":"10.1182\/BLOOD-2004-04-1325"},{"key":"9197_CR127","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1365-2249.2006.03152.x","volume":"145","author":"TH Scott-Taylor","year":"2006","unstructured":"Scott-Taylor TH, Green MR, Raeiszadeh M et al (2006) Defective maturation of dendritic cells in common variable immunodeficiency. Clin Exp Immunol 145:420\u2013427. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03152.x","journal-title":"Clin Exp Immunol"},{"key":"9197_CR128","doi-asserted-by":"publisher","unstructured":"Paquin-Proulx D, Santos BAN, Carvalho KI, et al (2013) Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment. Blood 121:4963\u20134964. https:\/\/doi.org\/10.1182\/BLOOD-2013-04-499442","DOI":"10.1182\/BLOOD-2013-04-499442"},{"key":"9197_CR129","unstructured":"Nourizadeh M, Aghamohammadi A, Moazzeni SM, et al (2007) High Production of IL-18 by Dendritic Cells Induced by Sera from Patients with Primary Antibody Deficiency"},{"key":"9197_CR130","doi-asserted-by":"publisher","unstructured":"Botelho Alves P, Pires Pereira H, Costa Carvalho J, et al (2024) Expression of IL-17RA in Innate Cells of Patients with Common Variable Immunodeficiency (CVID) and its Clinical Implications. Eur Ann Allergy Clin Immunol. https:\/\/doi.org\/10.23822\/eurannaci.1764-1489.326","DOI":"10.23822\/eurannaci.1764-1489.326"},{"key":"9197_CR131","doi-asserted-by":"crossref","unstructured":"Cunningham-Rundles C, Radigan L, Knight AK, et al (2006) TLR9 Activation Is Defective in Common Variable Immune Deficiency1","DOI":"10.4049\/jimmunol.176.3.1978"},{"key":"9197_CR132","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4049\/jimmunol.1800102","volume":"202","author":"M Vlkova","year":"2019","unstructured":"Vlkova M, Chovancova Z, Nechvatalova J et al (2019) Neutrophil and granulocytic myeloid-derived suppressor cell\u2013mediated T cell suppression significantly contributes to immune dysregulation in common variable immunodeficiency disorders. J Immunol 202:93\u2013104. https:\/\/doi.org\/10.4049\/jimmunol.1800102","journal-title":"J Immunol"},{"key":"9197_CR133","doi-asserted-by":"publisher","unstructured":"Slanina P, Stichova J, Bosakova V, et al (2024) Phenotype and oxidative burst of low-density neutrophil subpopulations are altered in common variable immunodeficiency patients. Cytometry B Clin Cytom 106:99\u2013112. https:\/\/doi.org\/10.1002\/cyto.b.22150","DOI":"10.1002\/cyto.b.22150"},{"key":"9197_CR134","doi-asserted-by":"publisher","unstructured":"Litzman J, Chovancov\u00e1 Z, Bejd\u00e1k P, et al (2019) Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase. Int J Immunopathol Pharmacol 33:. https:\/\/doi.org\/10.1177\/2058738419843381","DOI":"10.1177\/2058738419843381"},{"key":"9197_CR135","doi-asserted-by":"publisher","unstructured":"Sim\u00f3n-Fuentes M, S\u00e1nchez-Ram\u00f3n S, Fern\u00e1ndez-Paredes L, et al (2022) Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients. J Clin Immunol 42:1093\u20131105. https:\/\/doi.org\/10.1007\/S10875-022-01277-7,","DOI":"10.1007\/S10875-022-01277-7,"},{"key":"9197_CR136","doi-asserted-by":"publisher","unstructured":"van Stigt AC, von der Th\u00fcsen JH, Mustafa DAM, et al (2025) Granulomas in Common Variable Immunodeficiency Display Different Histopathological Features Compared to Other Granulomatous Diseases. J Clin Immunol 45:. https:\/\/doi.org\/10.1007\/s10875-024-01817-3","DOI":"10.1007\/s10875-024-01817-3"},{"key":"9197_CR137","doi-asserted-by":"publisher","unstructured":"Geier CB, Kraupp S, Bra D, et al (2017) Reduced numbers of circulating group 2 innate lymphoid cells in patients with common variable immunodeficiency. Eur J Immunol 47:1959\u20131969. https:\/\/doi.org\/10.1002\/eji.201746961","DOI":"10.1002\/eji.201746961"},{"key":"9197_CR138","doi-asserted-by":"publisher","unstructured":"Friedmann D, Keller B, Harder I, et al (2017) Preferential Reduction of Circulating Innate Lymphoid Cells Type 2 in Patients with Common Variable Immunodeficiency with Secondary Complications Is Part of a Broader Immune Dysregulation. J Clin Immunol 37:759\u2013769. https:\/\/doi.org\/10.1007\/s10875-017-0444-0","DOI":"10.1007\/s10875-017-0444-0"},{"key":"9197_CR139","unstructured":"Ganjalikhani-Hakemi M, Yazdani R, Sherkat R, et al (2014) Evaluation of the T helper 17 cell specific genes and the innate lymphoid cells counts in the peripheral blood of patients with the common variable immunodeficiency"},{"key":"9197_CR140","doi-asserted-by":"publisher","unstructured":"Cols M, Rahman A, Maglione PJ, et al (2016) Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. Journal of Allergy and Clinical Immunology 137:1206\u20131215.e6. https:\/\/doi.org\/10.1016\/j.jaci.2015.09.013","DOI":"10.1016\/j.jaci.2015.09.013"},{"key":"9197_CR141","doi-asserted-by":"publisher","unstructured":"Cunningham-Rundles C, Radigan L (2005) Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clinical Immunology 115:147\u2013153. https:\/\/doi.org\/10.1016\/j.clim.2004.12.007","DOI":"10.1016\/j.clim.2004.12.007"},{"key":"9197_CR142","doi-asserted-by":"publisher","unstructured":"Hayes KM, Boldt K, Schnorr PJ, et al (2026) Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiency. JCI Insight 11:. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.198703","DOI":"10.1172\/JCI.INSIGHT.198703"},{"key":"9197_CR143","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/clin.1994.1032","volume":"70","author":"P Aukrust","year":"1994","unstructured":"Aukrust P, M\u00fcller F, Fr\u00f8land SS (1994) Elevated serum levels of interleukin-4 and inteleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol 70:217\u2013224. https:\/\/doi.org\/10.1006\/clin.1994.1032","journal-title":"Clin Immunol Immunopathol"},{"key":"9197_CR144","doi-asserted-by":"publisher","unstructured":"Aukrust P, Lien E, Kristoffersen AK, et al (1996) Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2013possible immunologic and clinical consequences. Blood 87:674\u2013681. https:\/\/doi.org\/10.1182\/blood.v87.2.674.bloodjournal872674","DOI":"10.1182\/blood.v87.2.674.bloodjournal872674"},{"key":"9197_CR145","doi-asserted-by":"publisher","unstructured":"Poto R, Pecoraro A, Ferrara AL, et al (2023) Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID). Front Immunol 14:. https:\/\/doi.org\/10.3389\/FIMMU.2023.1257398","DOI":"10.3389\/FIMMU.2023.1257398"},{"key":"9197_CR146","doi-asserted-by":"publisher","unstructured":"Yang M, Kaarb\u00f8 M, Myhre V, et al (2026) Distinct Proteomic and Transcriptomic Profiles in T-cells and Monocytes in Patients with Common Variable Immunodeficiency: an Exploratory Study. Journal of Clinical Immunology 2026 46:1 46:72-. https:\/\/doi.org\/10.1007\/S10875-026-02016-Y","DOI":"10.1007\/S10875-026-02016-Y"},{"key":"9197_CR147","doi-asserted-by":"publisher","unstructured":"Holm AM, Aukrust P, Aandahl EM, et al (2003) Impaired Secretion of IL-10 by T Cells from Patients with Common Variable Immunodeficiency\u2013Involvement of Protein Kinase A Type I. The Journal of Immunology 170:5772\u20135777. https:\/\/doi.org\/10.4049\/JIMMUNOL.170.11.5772","DOI":"10.4049\/JIMMUNOL.170.11.5772"},{"key":"9197_CR148","doi-asserted-by":"publisher","unstructured":"Zhou Z, Huang R, Danon M, et al (1998) IL-10 production in common variable immunodeficiency. Clin Immunol Immunopathol 86:298\u2013304. https:\/\/doi.org\/10.1006\/clin.1997.4483","DOI":"10.1006\/clin.1997.4483"},{"key":"9197_CR149","doi-asserted-by":"publisher","unstructured":"Sharifi L, Aghamohammadi A, Rezaei N, et al (2019) Interleukin-1\u03b2 and interleukin-6 in Common Variable Immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine. Eur Cytokine Netw 30:123\u2013129. https:\/\/doi.org\/10.1684\/ECN.2019.0435","DOI":"10.1684\/ECN.2019.0435"},{"key":"9197_CR150","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Ubreva J, Calafell-Segura J, Calvillo CL, et al (2024) COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation. Nat Commun 15:. https:\/\/doi.org\/10.1038\/S41467-024-54732-X","DOI":"10.1038\/S41467-024-54732-X"},{"key":"9197_CR151","doi-asserted-by":"publisher","unstructured":"Masle-Farquhar E, Jeelall Y, White J, et al (2023) CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1\u2009+\u2009ICOShigh activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells. Front Immunol 14:1095257. https:\/\/doi.org\/10.3389\/FIMMU.2023.1095257\/FULL","DOI":"10.3389\/FIMMU.2023.1095257\/FULL"},{"key":"9197_CR152","doi-asserted-by":"publisher","unstructured":"Schubert D, Bode C, Kenefeck R, et al (2014) Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 20:1410. https:\/\/doi.org\/10.1038\/NM.3746","DOI":"10.1038\/NM.3746"},{"key":"9197_CR153","doi-asserted-by":"publisher","unstructured":"Kuehn HS, Ouyang W, Lo B, et al (2014) Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345:1623. https:\/\/doi.org\/10.1126\/SCIENCE.1255904","DOI":"10.1126\/SCIENCE.1255904"},{"key":"9197_CR154","doi-asserted-by":"publisher","unstructured":"Lougaris V, Baronio M, Gazzurelli L, et al (2018) A de novo monoallelic CTLA-4 deletion causing pediatric onset CVID with recurrent autoimmune cytopenias and severe enteropathy. Clinical Immunology 197:186\u2013188. https:\/\/doi.org\/10.1016\/j.clim.2018.10.007","DOI":"10.1016\/j.clim.2018.10.007"},{"key":"9197_CR155","doi-asserted-by":"publisher","unstructured":"Verma N, Burns SO, Walker LSK, Sansom DM (2017) Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations. Clin Exp Immunol 190:1. https:\/\/doi.org\/10.1111\/CEI.12997","DOI":"10.1111\/CEI.12997"},{"key":"9197_CR156","doi-asserted-by":"publisher","unstructured":"Grimbacher B, Hutloff A, Schlesier M, et al (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4:261\u2013268. https:\/\/doi.org\/10.1038\/NI902","DOI":"10.1038\/NI902"},{"key":"9197_CR157","doi-asserted-by":"publisher","unstructured":"Warnatz K, Bossaller L, Salzer U, et al (2006) Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107:3045\u20133052. https:\/\/doi.org\/10.1182\/BLOOD-2005-07-2955","DOI":"10.1182\/BLOOD-2005-07-2955"},{"key":"9197_CR158","doi-asserted-by":"publisher","unstructured":"Abolhassani H, El-Sherbiny YM, Arumugakani G, et al (2020) Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency. J Clin Immunol 40:277\u2013288. https:\/\/doi.org\/10.1007\/S10875-019-00735-Z","DOI":"10.1007\/S10875-019-00735-Z"},{"key":"9197_CR159","doi-asserted-by":"publisher","unstructured":"Cunningham-Rundles C, Casanova JL, Boisson B (2023) Genetics and clinical phenotypes in common variable immunodeficiency. Front Genet 14:1272912. https:\/\/doi.org\/10.3389\/FGENE.2023.1272912\/TEXT","DOI":"10.3389\/FGENE.2023.1272912\/TEXT"},{"key":"9197_CR160","doi-asserted-by":"publisher","unstructured":"Udemgba C, Pillay B, Shafer S, et al (2025) IRF2BP2 deficiency: An important form of common variable immunodeficiency with inflammation. Journal of Allergy and Clinical Immunology 155:2052\u20132062.e5. https:\/\/doi.org\/10.1016\/J.JACI.2025.02.038","DOI":"10.1016\/J.JACI.2025.02.038"},{"key":"9197_CR161","doi-asserted-by":"publisher","unstructured":"Keller MD, Pandey R, Li D, et al (2016) Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder. Journal of Allergy and Clinical Immunology 138:544\u2013550.e4. https:\/\/doi.org\/10.1016\/J.JACI.2016.01.018","DOI":"10.1016\/J.JACI.2016.01.018"},{"key":"9197_CR162","doi-asserted-by":"publisher","unstructured":"Lo B, Zhang K, Lu W, et al (2015) Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science (1979) 349:436\u2013440. https:\/\/doi.org\/10.1126\/SCIENCE.AAA1663;WEBSITE:WEBSITE:AAAS-SITE;ISSUE:ISSUE:DOI","DOI":"10.1126\/SCIENCE.AAA1663;WEBSITE:WEBSITE:AAAS-SITE;ISSUE:ISSUE:DOI"},{"key":"9197_CR163","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/08820139.2020.1833029","volume":"51","author":"F Salami","year":"2022","unstructured":"Salami F, Fekrvand S, Yazdani R et al (2022) Evaluation of expression of LRBA and CTLA-4 proteins in common variable immunodeficiency patients. Immunol Invest 51:381\u2013394. https:\/\/doi.org\/10.1080\/08820139.2020.1833029","journal-title":"Immunol Invest"},{"key":"9197_CR164","doi-asserted-by":"publisher","unstructured":"Tuijnenburg P, Lango Allen H, Burns SO, et al (2018) Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J Allergy Clin Immunol 142:1285. https:\/\/doi.org\/10.1016\/J.JACI.2018.01.039","DOI":"10.1016\/J.JACI.2018.01.039"},{"key":"9197_CR165","doi-asserted-by":"publisher","unstructured":"Dieli-Crimi R, Mart\u00ednez-Gallo M, Franco-Jarava C, et al (2018) Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations. Clinical Immunology 195:49\u201358. https:\/\/doi.org\/10.1016\/j.clim.2018.07.015","DOI":"10.1016\/j.clim.2018.07.015"},{"key":"9197_CR166","doi-asserted-by":"publisher","unstructured":"Lorenzini T, Fliegauf M, Klammer N, et al (2020) Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. Journal of Allergy and Clinical Immunology 146:901\u2013911. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.051","DOI":"10.1016\/j.jaci.2019.11.051"},{"key":"9197_CR167","doi-asserted-by":"publisher","unstructured":"Lindsley AW, Qian Y, Valencia CA, et al (2014) Combined immune deficiency in a patient with a novel NFKB2 mutation. J Clin Immunol 34:910\u2013915. https:\/\/doi.org\/10.1007\/S10875-014-0095-3","DOI":"10.1007\/S10875-014-0095-3"},{"key":"9197_CR168","doi-asserted-by":"publisher","unstructured":"Lougaris V, Tabellini G, Vitali M, et al (2015) Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease. Journal of Allergy and Clinical Immunology 135:1641\u20131643.e3. https:\/\/doi.org\/10.1016\/j.jaci.2014.11.038","DOI":"10.1016\/j.jaci.2014.11.038"},{"key":"9197_CR169","doi-asserted-by":"publisher","unstructured":"Liu Y, Hanson S, Gurugama P, et al (2014) Novel NFKB2 Mutation in Early-Onset CVID. Journal of Clinical Immunology 2014 34:6 34:686\u2013690. https:\/\/doi.org\/10.1007\/S10875-014-0064-X","DOI":"10.1007\/S10875-014-0064-X"},{"key":"9197_CR170","doi-asserted-by":"publisher","unstructured":"Nunes-Santos CJ, Uzel G, Rosenzweig SD (2019) PI3K pathway defects leading to immunodeficiency and immune dysregulation. Journal of Allergy and Clinical Immunology 143:1676\u20131687. https:\/\/doi.org\/10.1016\/j.jaci.2019.03.017","DOI":"10.1016\/j.jaci.2019.03.017"},{"key":"9197_CR171","doi-asserted-by":"publisher","unstructured":"Preite S, Gomez-Rodriguez J, Cannons JL, Schwartzberg PL (2019) T and B-cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity. Immunol Rev 291:154\u2013173. https:\/\/doi.org\/10.1111\/IMR.12790","DOI":"10.1111\/IMR.12790"},{"key":"9197_CR172","doi-asserted-by":"publisher","unstructured":"Conley ME, Dobbs AK, Quintana AM, et al (2012) Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K. Journal of Experimental Medicine 209:463\u2013470. https:\/\/doi.org\/10.1084\/JEM.20112533","DOI":"10.1084\/JEM.20112533"},{"key":"9197_CR173","doi-asserted-by":"publisher","unstructured":"Nguyen T, Lau A, Bier J, et al (2023) Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3K\u03b4 syndrome 2. Journal of Experimental Medicine 220:. https:\/\/doi.org\/10.1084\/JEM.20221020\/213955","DOI":"10.1084\/JEM.20221020\/213955"},{"key":"9197_CR174","doi-asserted-by":"publisher","unstructured":"Russell MA, Pigors M, Houssen ME, et al (2018) A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID). Clin Immunol 187:132\u2013136. https:\/\/doi.org\/10.1016\/J.CLIM.2017.11.007","DOI":"10.1016\/J.CLIM.2017.11.007"},{"key":"9197_CR175","doi-asserted-by":"publisher","unstructured":"Erd\u0151s M, Tsumura M, K\u00e1llai J, et al (2021) Novel STAT-3 gain\u2010of\u2010function variant with hypogammaglobulinemia and recurrent infection phenotype. Clin Exp Immunol 205:354. https:\/\/doi.org\/10.1111\/CEI.13625","DOI":"10.1111\/CEI.13625"},{"key":"9197_CR176","doi-asserted-by":"publisher","unstructured":"Schepp J, Chou J, Skrabl-Baumgartner A, et al (2017) 14 years after discovery: Clinical follow-up on 15 patients with inducible co-stimulator deficiency. Front Immunol 8:279847. https:\/\/doi.org\/10.3389\/FIMMU.2017.00964\/TEXT","DOI":"10.3389\/FIMMU.2017.00964\/TEXT"},{"key":"9197_CR177","doi-asserted-by":"publisher","unstructured":"Liu A, Liu Q, Leng S, et al (2023) Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID. Clin Exp Immunol 211:68\u201377. https:\/\/doi.org\/10.1093\/CEI\/UXAC121","DOI":"10.1093\/CEI\/UXAC121"},{"key":"9197_CR178","doi-asserted-by":"publisher","unstructured":"G\u00e1mez-D\u00edaz L, Seidel MG (2021) Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies. Front Pediatr 9:662645. https:\/\/doi.org\/10.3389\/FPED.2021.662645\/TEXT","DOI":"10.3389\/FPED.2021.662645\/TEXT"},{"key":"9197_CR179","doi-asserted-by":"publisher","unstructured":"Tromp SAM, van Leeuwen EMM, Jansen MH, et al (2025) Novel pathogenic variants in CTLA4 and LRBA immune dysregulation: Reduced CTLA-4 expression with normal expression of co-stimulatory surface molecules. Clinical Immunology 280:. https:\/\/doi.org\/10.1016\/j.clim.2025.110565","DOI":"10.1016\/j.clim.2025.110565"},{"key":"9197_CR180","doi-asserted-by":"publisher","unstructured":"Danieli MG, Pedini V, Menghini D, et al (2019) A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept. Arch Clin Med Case Rep 03: https:\/\/doi.org\/10.26502\/ACMCR.96550124","DOI":"10.26502\/ACMCR.96550124"},{"key":"9197_CR181","doi-asserted-by":"publisher","unstructured":"Shi C, Wang F, Tong A, et al (2016) NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literature. Medicine 95:. https:\/\/doi.org\/10.1097\/MD.0000000000005081","DOI":"10.1097\/MD.0000000000005081"},{"key":"9197_CR182","doi-asserted-by":"publisher","unstructured":"Zhang X, Wang J, Zhu K, et al (2021) Activated phosphoinositide 3-kinase delta syndrome misdiagnosed as anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report. Journal of International Medical Research 49:. https:\/\/doi.org\/10.1177\/03000605211013222;WGROUP:STRING:PUBLICATION","DOI":"10.1177\/03000605211013222;WGROUP:STRING:PUBLICATION"},{"key":"9197_CR183","doi-asserted-by":"publisher","unstructured":"Tangye SG, Bier J, Lau A, et al (2019) Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD\u2014the Goldilocks\u2019 Effect. J Clin Immunol 39:148\u2013158. https:\/\/doi.org\/10.1007\/S10875-019-00612-9","DOI":"10.1007\/S10875-019-00612-9"},{"key":"9197_CR184","doi-asserted-by":"publisher","unstructured":"Deau MC, Heurtier L, Frange P, et al (2014) A human immunodeficiency caused by mutations in the PIK3R1 gene. Journal of Clinical Investigation 124:3923\u20133928. https:\/\/doi.org\/10.1172\/JCI75746","DOI":"10.1172\/JCI75746"},{"key":"9197_CR185","doi-asserted-by":"publisher","unstructured":"Lucas CL, Kuehn HS, Zhao F, et al (2014) Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol 15:88\u201397. https:\/\/doi.org\/10.1038\/NI.2771","DOI":"10.1038\/NI.2771"},{"key":"9197_CR186","doi-asserted-by":"publisher","unstructured":"Preite S, Huang B, Cannons JL, et al (2019) PI3K Orchestrates T Follicular Helper Cell Differentiation in a Context Dependent Manner: Implications for Autoimmunity. Front Immunol 9:3079. https:\/\/doi.org\/10.3389\/FIMMU.2018.03079","DOI":"10.3389\/FIMMU.2018.03079"},{"key":"9197_CR187","doi-asserted-by":"publisher","unstructured":"Wentink M, Dalm V, Lankester AC, et al (2017) Genetic defects in PI3K\u03b4 affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol 176:77\u201386. https:\/\/doi.org\/10.1016\/J.CLIM.2017.01.004","DOI":"10.1016\/J.CLIM.2017.01.004"},{"key":"9197_CR188","doi-asserted-by":"publisher","unstructured":"Edwards ESJ, Bier J, Cole TS, et al (2019) Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. J Allergy Clin Immunol 143:276\u2013291.e6. https:\/\/doi.org\/10.1016\/J.JACI.2018.04.030","DOI":"10.1016\/J.JACI.2018.04.030"},{"key":"9197_CR189","doi-asserted-by":"publisher","unstructured":"Elkaim E, Neven B, Bruneau J, et al (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: A cohort study. Journal of Allergy and Clinical Immunology 138:210\u2013218.e9. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.022","DOI":"10.1016\/j.jaci.2016.03.022"},{"key":"9197_CR190","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/BLOOD-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner JD, Vogel TP, Forbes L et al (2015) Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125:591\u2013599. https:\/\/doi.org\/10.1182\/BLOOD-2014-09-602763","journal-title":"Blood"},{"key":"9197_CR191","doi-asserted-by":"publisher","unstructured":"Mohammadi A, Hamidi Esfahani Z, Abolhassani H et al (2026) ALPS-like Disorder Linked with STAT3 Mutation: De Novo Variant with Bicytopenia and Literature Review. Endocr Metab Immune Disord Drug Targets 26. https:\/\/doi.org\/10.2174\/0118715303470784260605093400","DOI":"10.2174\/0118715303470784260605093400"},{"key":"9197_CR192","doi-asserted-by":"publisher","unstructured":"Quinti I, Mitrevski M (2017) Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells. Front Immunol 8. https:\/\/doi.org\/10.3389\/FIMMU.2017.00697","DOI":"10.3389\/FIMMU.2017.00697"},{"key":"9197_CR193","doi-asserted-by":"publisher","unstructured":"Camacho-Ordonez N, Hirsch A, Campos L et al (2025) Do CVID patients on SCIG have more autoimmune (thrombo)cytopenic events than CVID patients on IVIG? Front Immunol 16. https:\/\/doi.org\/10.3389\/FIMMU.2025.1708813","DOI":"10.3389\/FIMMU.2025.1708813"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09197-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-026-09197-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09197-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:47:27Z","timestamp":1787903247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-026-09197-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9197"],"URL":"https:\/\/doi.org\/10.1007\/s12016-026-09197-9","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"70"}}